Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
Dendritic Cell Vaccine + Standard Therapy for Glioblastoma
Recruiting1 awardPhase 2
Durham, North Carolina
This trial is studying a vaccine as treatment for newly diagnosed glioblastoma. Patients will have surgery to remove the tumor, then have their blood drawn. From the blood, dendritic cells will be made. The patient will then receive standard radiation and chemotherapy, and during this treatment will also receive up to 10 injections of the dendritic cell vaccine. The vaccine will be given every 2 weeks, with each treatment cycle being 4 weeks long.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.